Autolus Therapeutics Balance Sheet (2017-2026)

Reported Financials

Autolus Therapeutics Quarterly Balance Sheet

Periods 34 quarters

Latest Jun 2026

Autolus Therapeutics reported total assets of $493.23M and total liabilities of $418.39M for the quarter ended Jun 2026, down 33.9% year over year. This balance sheet covers 34 quarters of results from Sep 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	216.35M	173.06M	310.34M	268.56M	216.44M	163.05M	382.44M	343.03M	307.50M	256.42M	239.57M	758.53M	705.94M	657.07M	227.38M	95.80M	123.83M	86.12M	104.13M	171.41M
Short-term InvestmentsInvestments (Current)	0.21M	0.21M	0.34M	0.33M	0.33M	0.32M	0.33M	0.33M	0.33M	0.43M	0.77M	1.01M	1.02M	1.47M	360.64M	420.80M	1.51M	281.30M	196.58M	30.22M
Cash & Current Investments	216.56M	173.27M	310.68M	268.89M	216.76M	163.37M	382.76M	343.36M	307.83M	256.85M	240.34M	759.54M	706.96M	658.54M	588.02M	516.60M	125.33M	367.42M	300.71M	201.63M
Receivables - NetNet Receivables						2.09M	0.12M	0.12M	0.10M	0.17M	0.11M				0.01M	14.32M	26.64M	32.60M	24.02M	44.40M
Receivables - OtherOther Receivables	1.81M	10.66M	0.38M	0.49M	0.37M	0.27M	1.44M	2.65M	1.73M	2.36M	0.52M	0.74M	0.96M	0.60M	0.49M	0.42M	0.67M	0.94M	0.92M	0.71M
Receivables			0.38M			2.36M	1.56M	2.77M	1.83M	2.52M	0.62M	0.74M	0.96M	0.60M	0.51M	14.74M	27.31M	33.54M	24.94M	45.11M
Inventory															4.14M	14.65M	23.94M	27.72M	33.21M	33.43M
Prepaid Assets	52.94M	64.41M	36.28M	40.57M	42.20M	48.94M	43.01M	50.53M	47.53M	51.53M	34.97M	44.75M	51.64M	59.58M	67.33M	68.78M	67.88M	85.34M	76.47M	55.14M
Current Assets	269.51M	237.68M	346.95M	309.46M	258.96M	212.31M	425.77M	393.88M	355.37M	308.38M	275.30M	804.30M	758.60M	718.11M	660.93M	615.77M	574.25M	514.58M	435.92M	336.09M
Non-Current Assets
Land & Improvements
Property, Plant & Equipment (Net)PP&E (Net)	34.19M	33.96M	33.54M	31.02M	33.79M	32.47M	35.21M	34.67M	36.86M	34.64M	34.86M	33.41M	32.86M	44.26M	49.55M	57.97M	66.47M	66.85M	63.56M	60.52M
Intangibles	0.11M	0.09M	0.07M	0.05M	0.03M	0.01M									12.37M	12.47M	12.93M	20.28M	19.81M	18.53M
Goodwill & Intangibles	0.11M	0.09M	0.07M	0.05M	0.03M	0.01M									12.37M	12.47M	12.93M	20.28M	19.81M	18.53M
Long-Term Deferred Tax	1.64M	1.41M	1.83M	2.00M	2.24M	2.40M	2.08M	2.27M	2.36M	2.60M	3.06M	3.29M	3.22M	3.39M	3.24M	2.76M	2.40M	2.39M	3.56M	2.79M
Other Non-Current Assets	1.85M	1.80M	2.36M	2.12M	1.89M	1.72M	2.18M	1.82M	1.86M	0.94M	0.98M	0.97M	0.98M	1.03M	0.96M	0.99M	5.26M	1.03M	1.03M	1.02M
Non-Current Assets	2.76M	2.51M	58.61M	54.53M	55.02M	51.52M	64.50M	66.09M	95.63M	97.72M	100.08M	97.14M	95.02M	109.38M	121.80M	130.56M	146.73M	147.37M	153.15M	157.13M
Assets	330.65M	296.64M	405.56M	363.99M	313.98M	263.83M	490.27M	459.97M	450.99M	406.10M	375.38M	901.44M	853.62M	827.49M	782.73M	746.34M	720.98M	661.95M	589.07M	493.23M
Liabilities
Current Liabilities
Accounts Payables	1.12M	1.46M	0.43M	0.15M	0.16M	0.33M	0.53M	0.35M	3.88M	0.66M	0.10M	1.40M	1.10M	1.42M	1.97M	4.46M	5.41M	10.97M	3.08M	1.37M
Payables	1.12M	1.46M	0.43M	0.15M	0.16M	0.33M	0.53M	0.35M	3.88M	0.66M	0.10M	1.40M	1.10M	1.42M	1.97M	4.46M	5.41M	10.97M	3.08M	1.37M
Accumulated Expenses	23.17M	28.63M	23.67M	24.51M	31.36M	34.67M	40.80M	34.46M	30.95M	31.39M	39.58M	37.77M	35.58M	47.49M	52.28M	49.66M	51.37M	52.26M	55.79M	48.73M
Current Leases	3.90M	4.47M	4.45M	4.17M	4.00M	3.81M	5.04M	4.82M	6.23M	5.49M	5.05M	4.82M	4.23M	3.57M	3.00M	2.97M	3.28M	4.83M	4.57M	5.79M
Current Deferred Revenue			47.00M	48.80M	50.60M	52.40M	35.00M	130.80M	135.80M	140.80M		188.50M	195.90M	203.40M		4.72M	2.10M	7.61M
Total Current Liabilities	28.19M	34.56M	28.55M	28.84M	35.52M	38.82M	46.37M	39.64M	41.06M	37.54M	44.74M	43.98M	40.90M	52.47M	60.74M	66.61M	68.15M	83.07M	73.44M	68.79M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue			47.02M	48.81M	50.62M	52.44M	125.90M	130.81M	135.76M	140.78M	170.90M	228.49M	238.66M	248.94M	244.60M	253.44M
Operating Leases	18.79M	17.34M	21.00M	15.08M	13.21M	11.31M	24.26M	22.50M	44.71M	46.97M	52.97M	51.34M	50.02M	52.23M	52.63M	57.71M	64.53M	65.83M	66.82M	83.51M
Other Non-Current Liabilities			0.13M	0.12M	0.12M	0.10M	0.12M	0.11M	0.12M	0.29M	0.36M	0.41M	0.41M	0.45M	0.43M	0.44M	0.48M	0.47M	0.48M	0.47M
Total Non-Current Liabilities			92.11M	92.73M	99.34M	102.57M	191.48M	192.94M	221.53M	225.28M	263.55M	319.00M	325.36M	350.08M	354.97M	374.79M	374.04M	396.02M	410.46M	417.91M
Total Liabilities	46.97M	51.91M	92.24M	92.85M	99.45M	102.68M	191.60M	193.05M	221.66M	225.58M	263.91M	319.41M	325.78M	350.52M	355.40M	375.23M	374.52M	396.50M	410.94M	418.39M
Shareholder's Equity
Total Debt
Common Equity	283.68M	244.73M	313.32M	271.14M	214.52M	161.15M	298.67M	266.92M	229.34M	180.52M	111.47M	582.03M	527.84M	476.96M	427.32M	371.11M	346.46M	265.45M	178.13M	74.84M
Liabilities and Shareholders Equity	330.65M	296.64M	405.56M	363.99M	313.98M	263.83M	490.27M	459.97M	450.99M	406.10M	375.38M	901.44M	853.62M	827.49M	782.73M	746.34M	720.98M	661.95M	589.07M	493.23M
Retained Earnings	732.29M	733.79M	843.11M	845.45M	848.37M	851.82M	1,007.62M	1,010.04M	1,012.71M	1,015.58M	1,018.90M	1,542.09M	1,545.15M	1,549.35M	1,555.59M	1,558.47M	1,562.77M	1,566.66M	1,570.11M	1,578.27M

Autolus Therapeutics AUTL Balance Sheet (2017-2026)

Autolus Therapeutics Quarterly Balance Sheet

Create an account

Sign In

Reset Password